Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture for Mild-Moderate COVID-19
NCT04844710Completed
- Sponsor
- Universitas Indonesia
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Changes of percentage of lymphocyte count at 2 weeks, Changes of Erythrocyte sedimentation rate at 2 weeks and 3 more. Started Sep 2020; status: completed.
Beyond the preview
Go deeper on NCT04844710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04844710.